Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
HM-001 by HOIST for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
HM-001 is under clinical development by HOIST and currently in Phase II for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial...